Skip to main content

Table 3 P-values for the pairwise comparisons of the level of prehension, total consumption, useful consumption and refusal for each product

From: Comparative palatability of five supplements designed for cats suffering from chronic renal disease

Product comparisons Prehension Total consumption Useful consumption Refusal
Ipakitine vs Renalzin 0.6293 1.0000 0.0005* 0.3383
Ipakitine vs Azodyl 0.9207 0.0011* <.0001* 0.7038
Ipakitine vs Rubenal 0.1450 0.0786 0.0118* 0.0076
Ipakitine vs Pronefra 0.0023* <.0001* <.0001* <.0001*
Renalzin vs Azodil 0.7039 0.0011* 0.0336* 0.1838
Renalzin vs Rubenal 0.3176 0.0786 0.2906 0.0784
Renalzin vs Pronefra 0.0008* <.0001* <.0001* <.0001*
Azodyl vs Rubenal 0.1758 0.0900 0.0022* 0.0026*
Azodyl vs Pronefra 0.0019* 0.1088 0.0459* 0.0002*
Rubenal vs Pronefra <.0001* 0.0013* <.0001* <.0001*
  1. Where products are significantly different, this is noted in bold with an asterisk.